SHAGA TECHNOLOGY CENTER · SPN-07
One Active Platform. Seven Engineered Formulations.
Advanced formulation architectures built around Spinosad — a blend of Spinosyn A and Spinosyn D — for professional vector-control delivery systems.
SHAGA FORMULATION ENGINEERING / 07 DELIVERY ARCHITECTURES
01 · Biological pathway
An interactive view of the biological target pathway associated with Spinosad activity.
Spinosad A&D particles enter the educational pathway visualization.
Educational visualization · not a quantitative simulation
Spinosad A&D particles enter the educational pathway visualization.
The active platform is represented approaching insect neural receptor pathways.
Activity is associated with altered signaling through nicotinic acetylcholine receptor pathways.
The diagram represents progressive disruption of coordinated insect neural signaling.
02 · Portfolio matrix
Compare SHAGA™ Spinosad delivery architectures by concentration, formulation system and operational profile.
SELECTED ARCHITECTURE · EC
03 · Formulation physics
One water-column instrument translates each formulation family into a clear, conceptual physical narrative.
ACTIVE FAMILY · EC
A representative concentrate droplet transitions into a distributed emulsion architecture in water.
A representative concentrate droplet transitions into a distributed emulsion architecture in water.
Concentrate → Water → EmulsionSuspended particles illustrate the physical delivery architecture of a dispersion-focused formulation.
Concentrate → Water → Suspended dispersionA conceptual zoom shows a finer representative droplet architecture without assigning an unsupported particle size.
Macro phase → Fine dispersion → Uniform distributionA compact preview of the two solid-dose systems developed further in the Tablet Engineering Lab.
Solid dose → Water contact → Distributed phase04 · Tablet engineering lab
Two tablet architectures designed around different field-preparation strategies.
Precision solid-dose system
Rapid water-dispersible solid dose
The sequences are conceptual formulation visualizations. No release time, dose, or field-performance value is implied.
Precision solid-dose system
Rapid water-dispersible solid dose
The sequences are conceptual formulation visualizations. No release time, dose, or field-performance value is implied.
05 · Platform architecture
A shared engineering platform translated into four distinct formulation families and seven portfolio configurations.
06 · Portfolio navigator
Use formulation architecture as a portfolio navigation lens — not as a dosing or application recommendation.
Navigate to the highest-concentration liquid architecture in the portfolio.
240 g/L · Emulsifiable Concentrate
Rapid EmulsificationNavigate to the highest-concentration liquid architecture in the portfolio.
24 ECExplore an EC platform positioned around consistent emulsification.
22 ECExplore a liquid architecture designed around suspended dispersion.
12.05 DCCompare the two micro-emulsion delivery platforms.
10 ME · 5 MENavigate to the controlled-delivery tablet architecture.
8.33 TNavigate to the water-dispersible tablet architecture.
7.48 DTExplore the lower-concentration micro-emulsion platform.
5 ME07 · Technology portfolio
A precise portfolio view built from formulation identity, concentration and architecture — without unsupported performance scoring.
LIQUID DELIVERY SYSTEM
LIQUID DELIVERY SYSTEM
LIQUID DELIVERY SYSTEM
LIQUID DELIVERY SYSTEM
SOLID-DOSE SYSTEM
SOLID-DOSE SYSTEM
LIQUID DELIVERY SYSTEM
08 · Claim discipline
A visible boundary between documented portfolio facts, technology language and claims that require label or study-level validation.
Verified formulation identity or concentration.
Describes intended formulation architecture.
Application and use statements requiring local label confirmation.
Performance claims requiring efficacy or stability evidence.
Formulation architecture describes how a delivery system is designed. It does not replace efficacy data, stability studies, regulatory authorization or the local product label.
SHAGA SPINOSAD TECHNOLOGY CENTER
